PR Newswire/Les Echos/
AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill., June 20, 2013 -- The board of directors of AbbVie Inc.
(NYSE: ABBV) declared a quarterly cash dividend of $0.40 per share.
The cash dividend is payable Aug. 15, 2013 to stockholders of record at the
close of business on July 15, 2013.
AbbVie was named to the S&P Dividend Aristocrats Index, which tracks companies
that have annually increased their dividend for at least 25 consecutive years.
AbbVie was included as a result of the Index's change in its treatment of
AbbVie is a global, research-based biopharmaceutical company formed in 2013
following separation from Abbott. The company's mission is to use its expertise,
dedicated people and unique approach to innovation to develop and market
advanced therapies that address some of the world's most complex and serious
diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and
markets medicines in more than 170 countries. For further information on the
company and its people, portfolio and commitments, please visit www.abbvie.com.
Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.
SOURCE AbbVie Inc.
CONTACT: Media, Adelle Infante, (847) 938-8745; Investors, Liz Shea, (847)
The content and accuracy of news releases published on this site and/or
distributed by PR Newswire or its partners are the sole responsibility of the
originating company or organisation. Whilst every effort is made to ensure the
accuracy of our services, such releases are not actively monitored or reviewed
by PR Newswire or its partners and under no circumstances shall PR Newswire or
its partners be liable for any loss or damage resulting from the use of such
information. All information should be checked prior to publication.
-0- Jun/21/2013 06:41 GMT
Press spacebar to pause and continue. Press esc to stop.